Formulary Search

Copper T380 A®

Nova T 380

T-Safe 380A  QL

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Prescribe generically - not to be prescribed by brand.

12 hour missed pill window with higher risk of irregular bleeding

Option for endometriosis

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Desorex, Zelletta, Feanolla, Cerelle, Desomono, Cerazette, Lovima -Do NOT prescribe by brand

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Preferred brands: Gedarel 20/150, Bimezza, Gedarel 30/150, Cimizt

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Mercilon, Marvilon - Not recommended for new initiations. Exisitng patients may remain on this brand.

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Preferred brands: Yacella, Dretine

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Lucette, Ellanite, Yasmin, Eloine - Not recommended for new initiations. Exisitng patients may remain on this brand.

Note a cost-effective choice. Consider only if compliance / swallowing difficulties / malabsorption with oral CHC and LARC is unsuitable.

SyreniRing is lower cost than NuvaRing and does not require refrigeration

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Microgynon 30 ED, TriRegol, Logynon, Logynon ED

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Preferred brands = Levest, Rigevidon, Maexeni,

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Ovranette / Ambelina / Microgynon 30 - not for new initiations. Existing patients may remain on current brand.

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Elevin brand is not a cost effective option. 

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Levosert

Mirena

May be particularly useful in women with heavy menstrual bleeding requiring (reversible) contraception.

Option for polycystic ovary syndrome.

RSFT: 2nd line for contraception and heavy menstrual bleeding for use when Benilexa is unsuitable of unavailable.

RSFT: Endometrial protection as part of HRT in both peri and postmenopausal women

Norgeston

progesterone only pill, POP

Jaydess 13.5mg

SASH: Jaydess is restriced to those patients who require a smaller size / lower dose of levonorgestrel

Kyleena 19.5mg.

RSFT: Kyleena should only be used in nulliparous patients under 25 years onld and those unable to use the alternative devices.

Benilexa One Handed

RSFT: 1st line for contraception and treatment of heavy menstrual bleeding for females between the ages of 18 and 45 years.

Option for polycystic ovary syndrome. May be particularly useful in women wih hevy menstrual bleeding requiring (reversible) contraception.

Sayana Press

Patients may be trained to self-administer Sayana Press

Depo Provera

CSM advice: Depo-Provera should only be used when other methods of contraception are inappropriate. Benefits of using medroxyprogesterone acetate beyond 2 years should be evalated against risk.

Women with risk factors for osteoporosis should consider alternative methos of contraception.

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

3 hour missed pill window

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Noristerat 200mg/1ml solution for injection

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Not a cost-effective choice. Consider only if compliance issues/swallowing difficulties/malabsorption with oral CHC and LARC is unsuitable.

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Not recommended for new initiations. Existing patients may remain on this brand.

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Not recommended for new initiations. Existing patients may remain on this brand.

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Not recommended for new initiations. Existing patients may remain on this brand.

Not recommended for new initiations. Exisitng patients may remain on this brand.